IOVANCE BIOTHERAPEUTICS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2019-11-04: Form 10-Q; Exhibit 10.2; Description First Amendment to the Lease Agreement, effective as of August 20, 2019, between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC..
- 2019-11-04: Form 10-Q; Exhibit 10.1; Description First Amendment to the Office Lease, effective as of June 19, 2019, between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC..
- 2019-08-01: Form 10-Q; Exhibit 10.1; Description Executive Employment Agreement effective as of July 18, 2019, by and between Friedrich-Reinhard Graf Finck von Finckenstein, M.D.#.
- 2019-06-21: Form 8-K; Exhibit 10.1; Description First Amendment to the Lease Agreement dated as of June 19, 2019, by and between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC..
| Filed | Form | Exhibit | Description |
|---|
| 2019-11-04 | 10-Q | 10.2 | First Amendment to the Lease Agreement, effective as of August 20, 2019, between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC. |
|---|
| 2019-11-04 | 10-Q | 10.1 | First Amendment to the Office Lease, effective as of June 19, 2019, between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC. |
|---|
| 2019-08-01 | 10-Q | 10.1 | Executive Employment Agreement effective as of July 18, 2019, by and between Friedrich-Reinhard Graf Finck von Finckenstein, M.D.# |
|---|
| 2019-06-21 | 8-K | 10.1 | First Amendment to the Lease Agreement dated as of June 19, 2019, by and between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC. |
|---|
| 2019-06-03 | 8-K | 10.1 | Lease Agreement dated as of May 28, 2019, by and between Iovance Biotherapeutics, Inc. and 300 Rouse Boulevard, LLC. |
|---|